Reiffel, James A.

Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: A Randomized Controlled Trial

Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., & Pratt, C. M. (2010) · JAMA

Atrial Fibrillation Management and OutcomesFatty Acid Research and Health

Cited by 201

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II

Essien, U. R., Holmes, D. N., Jackson, L. R., Fonarow, G. C., Mahaffey, K. W., Reiffel, J. A., Steinberg, B. A., Allen, L. A., Chan, P. S., Freeman, J. V., et al. (2018) · JAMA Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 155

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

Steinberg, B. A., Kim, S., Fonarow, G. C., Thomas, L., Ansell, J., Kowey, P. R., Mahaffey, K. W., Gersh, B. J., Hylek, E., Naccarelli, G., et al. (2014) · American Heart Journal

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 154

Antiarrhythmic effects of omega-3 fatty acids

Reiffel, J. A., & McDonald, A. (2006) · The American Journal of Cardiology

Fatty Acid Research and HealthCardiac electrophysiology and arrhythmias

Cited by 153

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 141

Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detection

Reiffel, J. A., Schwarzberg, R., & Murry, M. (2005) · The American Journal of Cardiology

ECG Monitoring and AnalysisCardiac electrophysiology and arrhythmias

Cited by 131

Drug‐Device Interactions: Clinical Considerations

REIFFEL, J. A., COROMILAS, J., ZIMMERMAN, J. M., & SPOTNITZ, H. M. (1985) · Pacing and Clinical Electrophysiology

Cardiac pacing and defibrillation studiesCardiac electrophysiology and arrhythmias

Cited by 49

Optimum duration of transtelephonic ECG monitoring when used for transient symptomatic event detection

Reiffel, J. A., Schulhof, E., Joseph, B., Severance, E., Wyndus, P., & McNamara, A. (1991) · Journal of Electrocardiology

ECG Monitoring and AnalysisCardiac pacing and defibrillation studies

Cited by 36

Cardiovascular benefits of icosapent ethyl in patients with and without atrial fibrillation in REDUCE-IT

Olshansky, B., Bhatt, D. L., Miller, M., Steg, P. G., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., et al. (2023) · Journal of the American Heart Association

Fatty Acid Research and HealthAtrial Fibrillation Management and Outcomes

Cited by 29